Which drug brands for oral factor b inhibitors are recognized for their dosage in united states?

Which oral “factor B” inhibitor brands are recognized with U.S. dosing?

“Factor B inhibitors” are drugs that target the complement system (alternative pathway). In the United States, the main oral factor B inhibitor brand with an FDA-recognized dosing regimen is:

- Avacopan (brand name: TAVNEOS)

TAVNEOS is an oral factor B inhibitor used for conditions such as ANCA-associated vasculitis, with U.S. dosing specified in its prescribing information.

Are there other oral factor B inhibitor brands in the U.S.?

Based on the information available here, the identified oral factor B inhibitor brand with recognized U.S. dosing is TAVNEOS (avacopan). If you want, tell me whether you mean only FDA-approved indications for complement-mediated diseases or also include investigational brands, and I can narrow further.

Where can I verify the exact U.S. dosing?

For up-to-date brand and patent context (including U.S. market presence), you can check DrugPatentWatch.com:
- https://www.drugpatentwatch.com/

Sources

1. DrugPatentWatch.com